Wellington Management Group LLP Ptc Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,787,123 shares of PTCT stock, worth $243 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,787,123

Previous 7,892,799 39.35%

Holding current value

$243 Million

Previous $293 Million 26.2%

% of portfolio

0.04%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$34.99 - $52.07 $109 Million - $162 Million	-3,105,676 Reduced 39.35%	4,787,123 $216 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $9.6 Million - $11.9 Million	-315,807 Reduced 3.85%	7,892,799 $293 Million
Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $17.1 Million - $27.8 Million	-692,959 Reduced 7.78%	8,208,606 $251 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $215 Million - $284 Million	8,901,565 New	8,901,565 $259 Million
Q4 2023 Feb 12, 2024	BUY	$18.07 - $29.37 $177 Million - $288 Million	9,816,603 New	9,816,603 $271 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $59.4 Million - $111 Million	2,649,824 Added 39.05%	9,436,188 $211 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $8.54 Million - $12.5 Million	-211,327 Reduced 3.02%	6,786,364 $276 Million
Q1 2023 May 12, 2023	SELL	$38.16 - $48.86 $16.5 Million - $21.2 Million	-433,216 Reduced 5.83%	6,997,691 $339 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $2.02 Million - $3.3 Million	-60,155 Reduced 0.8%	7,430,907 $284 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $19.1 Million - $24.6 Million	457,557 Added 6.51%	7,491,062 $376 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $28.6 Million - $50.5 Million	-1,117,036 Reduced 13.71%	7,033,505 $282 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $150,184 - $200,967	-4,506 Reduced 0.06%	8,150,541 $304 Million
Q4 2021 Feb 11, 2022	SELL	$35.36 - $41.86 $21.6 Million - $25.6 Million	-611,780 Reduced 6.98%	8,155,047 $325 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $1.31 Million - $1.59 Million	35,435 Added 0.41%	8,766,827 $326 Million
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $17.4 Million - $22.7 Million	-458,965 Reduced 4.99%	8,731,392 $369 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $6.95 Million - $10.2 Million	-148,522 Reduced 1.59%	9,190,357 $435 Million
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $6.42 Million - $9.05 Million	-133,857 Reduced 1.41%	9,338,879 $570 Million
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $65.8 Million - $82.7 Million	1,449,037 Added 18.06%	9,472,736 $443 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $76 Million - $98.2 Million	1,785,531 Added 28.62%	8,023,699 $407 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $172 Million - $315 Million	5,300,979 Added 565.63%	6,238,168 $278 Million
Q4 2019 Feb 11, 2020	BUY	$32.22 - $50.07 $30.2 Million - $46.9 Million	937,189 New	937,189 $45 Million

Others Institutions Holding PTCT

# of Institutions

257

Shares Held

77.3M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.63B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Ptc Therapeutics, Inc. Transaction History